COPENHAGEN, March 3 (Reuters) - The U.S. Food and Drug Administration has approved Danish drugmaker Novo Nordisk's growth hormone injection pen Norditropin Flexpro, the company said on Wednesday.

March 5, 2010 — The US Food and Drug Administration (FDA) has approved a prefilled somatropin (rDNA origin) injection pen (Norditropin FlexPro, Novo Nordisk, Inc) for the treatment of growth hormone ...

Rockland, Massachusetts, December 6, 2007 - EMD Serono, Inc. announced today the availability of easypod®, the first of its kind automated device in the growth hormone therapeutic area. easypod® was ...

It is now possible to study short-term growth by knemometry, a non-invasive technique measuring the exact distance between heel and knee in sitting children. During the measurement the lower leg ...

Pediatric growth hormone deficiency (PGHD) is a genetic condition that affects your child’s physical development. Hormone replacement therapy can help promote growth, and a new injection now makes it ...